HuGE Literature Finder
Records
1
-
6
Chromosomal Region 11p14.1 is Associated with Pharmacokinetics and Pharmacodynamics of Bisoprolol.
![]() Pharmacogenomics and personalized medicine 2022 4 15 249-260. Fontana Vanessa, Turner Richard Myles, Francis Ben, Yin Peng, Pütz Benno, Hiltunen Timo P, Ruotsalainen Sanni, Kontula Kimmo K, Müller-Myhsok Bertam, Pirmohamed Mun |
Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
The effect of the CYP2D6 genotype on the maintenance dose of metoprolol in a chronic Dutch patient population. Pharmacogenetics and genomics 2019 May . Poulussen Fenna C P, Peters Bas J, Hua Ken Ho, Houthuizen Patrick, Grouls Rene J, Deenen Maarten |
Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Frontiers in genetics 2012 3 . Roco A, Quiñones L, Agúndez JA, García-Martín E, Squicciarini V, Miranda C, Garay J, Farfán N, Saavedra I, Cáceres D, Ibarra C, Varela N |
The relevance of CYP2D6 genetic polymorphism on chronic metoprolol therapy in cardiovascular patients. Journal of clinical pharmacy and therapeutics 2006 Feb 31 (1): 99-109. Ismail R, Teh L |
Genetic polymorphism of CYP2D6 in patients with cardiovascular disease -- a cohort study. Journal of clinical pharmacy and therapeutics 2004 Dec 29 (6): 559-64. Teh L K, Zilfalil B A, Marina I, Rosemi B S, Ismail |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 07, 2023
- Content source: